Pan et al. identified and validated 10 cuproptosis-related lncRNAs in 12 BC patients and cell lines26, while Huang et al. concentrated on cuproptosis-related genes, identifying PDHA1 as an independent BC prognostic biomarker, validated in cell lines and a 30-sample tissue microarray27. This evidence concerns the gene PDHA1 and breast cancer.